Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders.
Publication/Presentation Date
9-1-2000
Abstract
The diagnosis and management of growth disorders in children, particularly disorders that respond to therapy with growth hormone (GH), raise challenging clinical and economic issues. Several such issues are presented in the following article in which Dr. Ron Rosenfeld examines the evaluation and diagnosis of the child with short stature; Dr. David B. Allen discusses the anabolic and metabolic indications for GH treatment in children; Dr. Margaret H. MacGillivray reviews GH dosing, height outcomes, and follow up; and Dr. Craig Alter presents the payer's perspective on the diagnosis and treatment of pediatric GH deficiency. In addressing the use of GH in other pediatric populations, Dr. Paul Saenger focuses on Turner syndrome, Dr. Henry Anhalt on chronic renal insufficiency of childhood, and Dr. Ray Hintz on idiopathic short stature. Dr. Harvey P. Katz presents one managed care organization's policy and implementation plan that is used to guide decisions regarding coverage for GH treatment.
Volume
6
Issue
15 Suppl
First Page
805
Last Page
816
ISSN
1088-0224
Published In/Presented At
Rosenfeld, R., Allen, D. B., MacGillivray, M. H., Alter, C., Saenger, P., Anhalt, H., Hintz, R., & Katz, H. P. (2000). Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders. The American journal of managed care, 6(15 Suppl), S805–S816.
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
11184422
Department(s)
Department of Pediatrics
Document Type
Article